N03.6
Chronic nephritic syndrome with dense deposit disease
Clinical Classification Guidelines
Inclusion Terms
- Chronic nephritic syndrome with C3 glomerulopathy with dense deposit disease
- Chronic nephritic syndrome with membranoproliferative glomerulonephritis, type 2
Medical Intelligence & Overview
Chronic nephritic syndrome with dense deposit disease is a rare kidney disorder characterized by ongoing inflammation of the glomeruli, which are tiny filtering units in the kidneys. This condition, classified as ICD-10 N03.6, often involves abnormal immune responses that damage the kidney tissue, leading to impaired kidney function over time. It is a form of C3 glomerulopathy, distinguished by dense deposits seen in the glomeruli under microscopic examination, and is associated with membranoproliferative glomerulonephritis type 2. Recognizing this condition early is vital for managing symptoms and preventing progression to kidney failure.
Causes & Symptoms
Clinical Causes: Abnormal activation of the complement system, particularly involving the alternative pathway Genetic mutations affecting complement regulation Autoimmune responses that target kidney tissues Idiopathic cases with no identifiable cause Possible association with other systemic diseases, such as certain infections
Key Symptoms: Hematuria (blood in the urine) Proteinuria (excess protein in the urine) Reduced urinary output Swelling in the legs, ankles, or around the eyes High blood pressure Fatigue and weakness Foamy urine caused by high protein levels Signs of kidney dysfunction, such as nausea or shortness of breath in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Kidney function is assessed through blood tests measuring creatinine and blood urea nitrogen (BUN). Urinalysis detects hematuria and proteinuria. A kidney biopsy provides definitive evidence by revealing dense deposits in the glomeruli characteristic of dense deposit disease. Complement levels, particularly C3, are often decreased, indicating abnormal immune activity. Imaging studies may be used to assess kidney size and structure, but biopsy remains essential for confirmation.
Treatment Protocols: Immunosuppressive medications to dampen immune responses Medications to control blood pressure, such as ACE inhibitors or ARBs Dietary modifications to reduce salt intake and support kidney health Plasma exchange in severe cases to remove abnormal immune substances Monitoring kidney function regularly to detect changes early Supportive care, including treatment for any complications like swelling or electrolyte imbalances
Clinical Advice & FAQs
Billing Guidance
Is N03.6 a billable ICD-10 code?
Yes, N03.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N03.6?
Clinical documentation must specify the nature of Chronic nephritic syndrome with dense deposit disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference